Laude K, Thuillez C, Richard V
INSERM E9920, Faculté de Médecine-Pharmacie de Rouen, Rouen Cedex, France.
Exp Clin Cardiol. 2001 Fall;6(3):149-52.
Although cardiac ischemia-reperfusion is well known as a disease of the myocytes, it is now clear that the consequences of this disease also extend to the vascular wall and especially to the endothelium. A rat model of ischemia-reperfusion in vivo was used to detect severe endothelial dysfunction characterized by a decreased nitric oxide (NO)-dependent relaxation to acetylcholine in isolated coronary arteries. Given the essential role of the endothelium and NO in the regulation of vascular tone, protection of the coronary endothelial cells is an important therapeutic target. For this purpose, a focus on the concept of endogenous protection against ischemia, ie, preconditioning, showed that endothelial dysfunction could be reversed by both the early and the delayed phase of preconditioning. With regard to the mechanisms of the coronaroprotective effects of preconditioning, it was shown that both free radicals and NO seem to have an important triggering role, leading to a delayed increase in NO production and decreased adhesion of neutrophils to endothelial cells. Identification of the precise triggers and mediators of this protection will allow the development of new therapeutic agents targeting both the myocardium and the coronary vasculature.
尽管心肌缺血再灌注作为一种心肌细胞疾病广为人知,但现在很清楚的是,这种疾病的后果也延伸到血管壁,尤其是内皮细胞。采用大鼠体内缺血再灌注模型来检测严重的内皮功能障碍,其特征是离体冠状动脉中对乙酰胆碱的一氧化氮(NO)依赖性舒张功能降低。鉴于内皮细胞和NO在血管张力调节中的重要作用,保护冠状动脉内皮细胞是一个重要的治疗靶点。为此,关注内源性抗缺血保护概念,即预处理,结果表明预处理的早期和延迟阶段均可逆转内皮功能障碍。关于预处理的冠状动脉保护作用机制,研究表明自由基和NO似乎都具有重要的触发作用,导致NO生成延迟增加以及中性粒细胞与内皮细胞的黏附减少。确定这种保护作用的确切触发因素和介质将有助于开发针对心肌和冠状动脉血管系统的新型治疗药物。